The executive summary is below and includes a list of stakeholder recommendations. The recommendations do not necessarily represent the views of the Alliance or a consensus among stakeholders.
It is imperative that we work to strengthen relationships and partnerships between the industry, government agencies, academic research organizations, philanthropies, procurement agencies, and multilateral organizations as a national and international community in order to optimize the global antiviral ecosystem for pandemic preparedness and response.View Executive Summary and Stakeholder Recommendations
Bridging the gap in antiviral solutions to viral pathogens with the greatest pandemic potential, requires innovation, commitment and collaboration across sectors. The INTREPID Alliance brings the experts and the platform needed to help ensure we are better prepared in the future."
And the Opening Fireside Chat WITH Susan Dentzer, President & CEO, America’s Physician Groups; Victor J. Dzau, M.D., President, U.S. National Academy of Medicine, Science & Technology Expert Group Co-Chair, and Member, International Pandemic Preparedness Secretariat Steering Group - (video) Heulwen Philpot, Head of the International Pandemic Preparedness Secretariat (IPPS) Matthew Hepburn, M.D., Senior Advisor to Director, White House Office of Science and Technology Policy (OSTP) for Pandemic Preparedness
The goal of the 100 Days Mission is to prepare as much as possible so that within the first 100 days that a pandemic threat is identified, the following interventions can be made available, safe, effective, and affordable:
Many profound thanks go to our board members, officers, moderators, speakers, Summit Organizing Commitee and over 100 attendees who participated in a robust, inspiring and solutions-oriented dialogue to begin laying out a roadmap toward the discovery, development and accessiblity of antirvirals for the next pandemic.